COVID-19 Americans are spending their stimulus cheques on weed: Headset Canadian cannabis 2.0 sales are on the rise and other weekly insights from the data firm Nick LabaApril 17, 2020
Cannabis Canopy closes international operations, expects up to $800M in charges The latest in a series of aggressive cutbacks spearheaded by new CEO David Klein Nick LabaApril 16, 2020
Canada Aphria remains profitable amid murk of insolvency The company reported steady growth over the latest fiscal period, but scaled back annual projections due to coronavirus concerns Nick LabaApril 15, 2020
The weed wire Revenues grow while earnings slow for Valens COVID-19 has cooled the overall demand for extraction services, but executives hold out hope for the rest of 2020 Nick LabaApril 14, 2020
Cannabis Organigram details revenue drop and debt violation in earnings report The company said lower general sales volumes were offset by higher medical and international sales Nick LabaApril 14, 2020
COVID-19 Cresco Labs to hire 250 service industry workers The company said it's upped wages for existing employees and started a lunch program to support local restaurants Nick LabaApril 13, 2020
Canada If your company is producing hand sanitizer to fight COVID-19, make sure it’s alcohol-based Valens and Neptune’s formulations are in line with official guidance, while others are not Nick LabaApril 9, 2020
The weed wire Trulieve posts record revenues in quarterly report The Floridian medical cannabis giant had a total of 44 stores nationwide by the end of 2019 Nick LabaApril 8, 2020
COVID-19 Ontario allows weed delivery and pickup to combat illicit market While store owners welcomed the news, more operational details have to be worked out Nick LabaApril 8, 2020
Health and Safety Stoner rat study first to closely mimic THC affinity in humans A new self-administration research model opens doors to fascinating questions that can't be explored in studies on people Nick LabaApril 7, 2020